Romero-Ibarguengoitia, M.E.; Rivera-Salinas, D.; Hernández-Ruíz, Y.G.; Armendariz-Vázquez, A.G.; González-Cantú, A.; Barco-Flores, I.A.; González-Facio, R.; Montelongo-Cruz, L.P.; Del Rio-Parra, G.F.; Sanz-Sánchez, M.Á.
Effect of Heterologous Vaccination Regimen with Ad5-nCoV CanSinoBio and BNT162b2 Pfizer in SARS-CoV-2 IgG Antibodies Titers. Vaccines 2022, 10, 392.
https://doi.org/10.3390/vaccines10030392
AMA Style
Romero-Ibarguengoitia ME, Rivera-Salinas D, Hernández-Ruíz YG, Armendariz-Vázquez AG, González-Cantú A, Barco-Flores IA, González-Facio R, Montelongo-Cruz LP, Del Rio-Parra GF, Sanz-Sánchez MÁ.
Effect of Heterologous Vaccination Regimen with Ad5-nCoV CanSinoBio and BNT162b2 Pfizer in SARS-CoV-2 IgG Antibodies Titers. Vaccines. 2022; 10(3):392.
https://doi.org/10.3390/vaccines10030392
Chicago/Turabian Style
Romero-Ibarguengoitia, Maria Elena, Diego Rivera-Salinas, Yodira Guadalupe Hernández-Ruíz, Ana Gabriela Armendariz-Vázquez, Arnulfo González-Cantú, Irene Antonieta Barco-Flores, Rosalinda González-Facio, Laura Patricia Montelongo-Cruz, Gerardo Francisco Del Rio-Parra, and Miguel Ángel Sanz-Sánchez.
2022. "Effect of Heterologous Vaccination Regimen with Ad5-nCoV CanSinoBio and BNT162b2 Pfizer in SARS-CoV-2 IgG Antibodies Titers" Vaccines 10, no. 3: 392.
https://doi.org/10.3390/vaccines10030392
APA Style
Romero-Ibarguengoitia, M. E., Rivera-Salinas, D., Hernández-Ruíz, Y. G., Armendariz-Vázquez, A. G., González-Cantú, A., Barco-Flores, I. A., González-Facio, R., Montelongo-Cruz, L. P., Del Rio-Parra, G. F., & Sanz-Sánchez, M. Á.
(2022). Effect of Heterologous Vaccination Regimen with Ad5-nCoV CanSinoBio and BNT162b2 Pfizer in SARS-CoV-2 IgG Antibodies Titers. Vaccines, 10(3), 392.
https://doi.org/10.3390/vaccines10030392
